Accessibility Menu
Kraig Biocraft Laboratories logo

Kraig Biocraft Laboratories

(OTC) KBLB

Current Price$0.12
Market Cap$132.45M
Since IPO (2008)+138%
5 Year-1%
1 Year+42%
1 Month-20%

Kraig Biocraft Laboratories Financials at a Glance

Market Cap

$132.45M

Revenue (TTM)

$0.00

Net Income (TTM)

-$3.97M

EPS (TTM)

-$0.00

P/E Ratio

-32.16

Dividend

$0.00

Beta (Volatility)

0.21 (Low)

Price

$0.12

Volume

86,205

Open

$0.12

Previous Close

$0.12

Daily Range

$0.12 - $0.12

52-Week Range

$0.07 - $0.16

Estimated Earnings Date

May 13, 2026

KBLB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kraig Biocraft Laboratories

Industry

Chemicals

Sector

Materials

Employees

14

CEO

Kim K. Thompson

Headquarters

Ann Arbor, MI 48104, US

KBLB Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

52%

Return on Assets

-1%

Earnings Yield

-3.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$132.45M

Shares Outstanding

1.11B

Volume

86.20K

Avg. Volume

1.37M

Financials (TTM)

Gross Profit

-$25.11K

Operating Income

-$3.37M

EBITDA

-$3.03M

Operating Cash Flow

-$1.79M

Capital Expenditure

-$5.40K

Free Cash Flow

-$1.79M

Cash & ST Invst.

$1.79M

Total Debt

$1.66M

Kraig Biocraft Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$6.22K

-9.5%

Gross Margin

0.00%

N/A

Market Cap

$132.45M

N/A

Market Cap/Employee

$3.58M

N/A

Employees

37

N/A

Net Income

-$942.72K

-57.1%

EBITDA

-$819.28K

-80.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$1.18M

+190.9%

Accounts Receivable

$0.00

N/A

Inventory

$74.31K

+979.4%

Long Term Debt

$106.43K

+182.1%

Short Term Debt

$1.61M

-2.6%

Return on Assets

-1.07%

N/A

Return on Invested Capital

52.04%

N/A

Free Cash Flow

-$543.83K

-25.2%

Operating Cash Flow

-$529.72K

-21.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WFSTFWestern Forest Products Inc.
$12.25-0.81%
GPACFGeopacific Resources Limited
$0.04+0.00%
ABSSFAirBoss of America Corp.
$5.28-2.76%
HHLKFHot Chili Limited
$1.37-6.98%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$79.21-0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.54-0.07%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$11.95-0.11%
ONDSOndas
$10.87-0.09%

Questions About KBLB

What is the current price of Kraig Biocraft Laboratories?

Kraig Biocraft Laboratories is trading at $0.12 per share.

What is the 52-week range for Kraig Biocraft Laboratories?

Over the past 52 weeks, Kraig Biocraft Laboratories has traded between $0.07 and $0.16.

How much debt does Kraig Biocraft Laboratories have?

As of the most recent reporting period, Kraig Biocraft Laboratories reported total debt of $1.72M.

How much cash does Kraig Biocraft Laboratories have on hand?

Kraig Biocraft Laboratories reported $2.89M in cash and cash equivalents in its most recent financial results.

What is Kraig Biocraft Laboratories’s dividend yield?

Kraig Biocraft Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.